Year-over-year, this metric grew by 119.3%, from $109.00M to $239.00M. Over 4 years (FY 2021 to FY 2025), Impairment and restructuring shows a downward trend with a -4.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
High levels indicate significant operational disruption or strategic realignment, often impacting short-term profitability.
The aggregate expense recognized for asset write-downs and costs associated with restructuring operations, such as facil...
Frequently used by capital-intensive firms to isolate non-recurring costs from core operating performance.
msft_impairment_and_restructuring| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.00M | $35.00M | $0.00 | $195.00M | $42.00M | $42.00M | $69.00M | $152.00M | $2.65B | $2.65B | $0.00 | $2.05B | $0.00 | $1.40B | $143.00M | $109.00M | $109.00M | $185.00M | $0.00 | $239.00M |
| QoQ Change | — | +0.0% | -100.0% | — | -78.5% | +0.0% | +64.3% | +120.3% | >999% | +0.0% | -100.0% | — | -100.0% | — | -89.8% | -23.8% | +0.0% | +69.7% | -100.0% | — |
| YoY Change | — | — | — | — | +20.0% | +20.0% | — | -22.1% | >999% | >999% | -100.0% | >999% | -100.0% | -47.2% | — | -94.7% | — | -86.8% | -100.0% | +119.3% |